Yesterday, Agendia officially opened its new headquarters in Amsterdam. In this new office the laboratory facilities are expanded. Dr. Bernhard Sixt, Agendia’s president & chief executive officer (CEO): "The expanded capacity of our laboratories at our new location will allow us to meet the growing worldwide demand for our clinical services as we expand into major markets, enhancing the company's ability to serve the healthcare community."

The new facilities offer 13,000 square feet of laboratory and office space that will support the company's molecular diagnostic cancer testing services and research activities.

During the opening René Bernards, scientific director of Agendia, announced the plans for Agendia to enter the stock market next year.

Source: Agendia and De Telegraaf